跳至主要内容
临床试验/NCT06861465
NCT06861465已完成不适用

eMPower Mechanisms: an Evidence-based Mental Wellness Programming Online for People With Primary Biliary Cholangitis - A Feasibility Randomized Controlled Trial

University of Alberta2 个研究点 分布在 1 个国家目标入组 18 人开始时间: 2025年2月21日最近更新:
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
18
试验地点
2
主要终点
Feasibility of the Intervention

研究概览

简要总结

Primary Biliary Cholangitis (PBC) is a chronic liver disease that can cause fatigue, itching, brain fog, and emotional distress, all of which can lower quality of life. While the standard treatment, ursodeoxycholic acid (UDCA), helps slow the disease, it does not relieve these symptoms. Research shows that mind-body practices-such as breathing exercises, meditation, and gentle movement-can help improve mental and physical well-being in people with chronic conditions, but their benefits for PBC are not yet well understood.

This study will test a 10-week online wellness program designed for women with PBC. The program will include guided breathing, meditation, and movement exercises, plus optional weekly group sessions and educational videos. Some participants will also receive nutrition guidance on the Mediterranean diet to see if it adds extra benefits.

The study will evaluate feasibility via recruitment, adherence, and retention. To assess acceptability, participants will provide feedback through surveys and interviews. The study will also explore early signs of effectiveness by measuring changes in symptoms like anxiety, depression, fatigue, and stress, as well as biological markers, brain activity, physical function, and data from wearable devices.

The results will help determine whether an online mind-body program, with or without nutrition support, could be a simple and effective way to help people with PBC manage their symptoms and improve their quality of life.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
40 Years 至 75 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Primary Biliary Cholangitis (PBC) as confirmed by a study Hepatologist using accepted clinical criteria
  • Have been on stable medical therapy for PBC for ≥3 months
  • Score ≥3 on a 1-10 numeric rating scale for two of: depression, anxiety, fatigue, sleep disturbance, cognitive impairment
  • Are able to communicate in English
  • Have access to an Internet-connected device in their home
  • Can commit to up to 60 minutes of study activities 5 days per week

排除标准

  • Unable to provide informed consent
  • Have decompensated cirrhosis including hepatic encephalopathy
  • Are post-liver transplant
  • Current severe substance use or psychiatric disorder judged to interfere with study testing or program participation
  • Are receiving compassionate care
  • Have a clinical condition that makes the intervention unsafe or infeasible (e.g. unable to follow instruction) or unsafe environment for virtual participation
  • Practices mind-body practices more than the study dose
  • Have contraindications for MRI
  • Have colour blindness
  • Are unable to attend baseline testing

研究组 & 干预措施

Experimental: Online Mind-Body Program

Active Comparator

Online program (mindful movement, meditation, breathwork)

干预措施: Online Mind-Body Wellness Program (Behavioral)

Experimental: Online Mind-Body Program + Nutritional Counselling

Experimental

Online program (mindful movement, meditation, breathwork) + nutritional counselling

干预措施: Online Mind-Body Wellness Program + Nutritional Counselling (Behavioral)

结局指标

主要结局

Feasibility of the Intervention

时间窗: Baseline and Week 10

Feasibility will be assessed by (i) adherence rate (percentage completing ≥70% of intervention, target ≥70%), and (ii) retention rate (percentage completing baseline and follow-up assessments, target ≥70%).

Acceptability of the Intervention

时间窗: Baseline and Week 10

Acceptability will be assessed via participant-reported satisfaction with the intervention using numerical surveys and perceived burden of study measures.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor
主要研究者

Puneeta Tandon

Associate Professor, Principal Investigator

University of Alberta

研究点 (2)

Loading locations...

相似试验